|
|
|
|
| LEADER |
00000cas#a2200000#a#4500 |
| 001 |
018130 |
| 003 |
AR-BeUNQ |
| 005 |
20230106115025.0 |
| 008 |
060904u19929999nyumu#p#######0###a0eng#d |
| 999 |
|
|
|c 27459
|d 110265
|
| 030 |
|
|
|a NGENEC
|
| 040 |
|
|
|a NSDP
|c NSDP
|d DNAL
|d MH
|d DNAL
|d DLC
|d NST
|d NSDP
|d DLC
|d NST
|d NSDP
|d NST
|d WaU
|d NST
|d OUCA
|d NST
|d OCoLC
|d DNAL
|d DNLM
|d NIC
|d DNLM
|d DLC
|d InU
|d PPBIO
|d DNAL
|d MH
|d MCM
|d GU
|d OCoLC
|d NSDP
|d N
|d OCoLC
|d DLC
|d AR-beUNQ
|e aacr
|
| 099 |
|
|
|a P-US-NAT3
|
| 210 |
0 |
|
|a Nat. genet.
|
| 245 |
0 |
0 |
|a Nature genetics.
|c Nature America Inc.
|
| 246 |
3 |
0 |
|a Genetics
|
| 260 |
|
|
|a New York, NY :
|b Nature Pub. Co.,
|
| 300 |
|
|
|a v. :
|
| 310 |
|
|
|a Mensual
|
| 362 |
0 |
|
|a Vol. 24, no. 2 (Feb. 2000)-
|
| 500 |
|
|
|a Descripción basada en: Vol. 24, no. 2 (Feb. 2000).
|
| 530 |
|
|
|a También disponible en versión en línea.
|
| 650 |
|
7 |
|a Genética
|2 Spines
|
| 650 |
|
7 |
|a Genes
|2 Spines
|
| 650 |
|
7 |
|a Evolución
|2 Spines
|
| 650 |
|
7 |
|a Farmacogenética
|2 Spines
|
| 650 |
|
7 |
|a Moléculas
|2 Spines
|
| 650 |
|
7 |
|a Cáncer
|2 toit
|
| 710 |
2 |
|
|a Nature America Inc.
|
| 856 |
|
|
|u https://web.s.ebscohost.com/ehost/command/detail?vid=0&sid=89211d83-25fc-40ff-984c-3e98226223aa%40redis&bdata=Jmxhbmc9ZXMmc2l0ZT1laG9zdC1saXZl#jid=1HH&db=aph
|u https://www.nature.com/ng/
|z Acceso a través de Becyt
|
| 866 |
0 |
|
|a 2000 24(2, 4); 2005 37(Supplement); 2007 39(2)
|
| 929 |
|
|
|d 0
|b Laboratorio de Oncología Molecular
|a DONACION
|j 38944 00001
|e 20050524
|
| 929 |
|
|
|d 0
|b Laboratorio de Oncología Molecular
|a DONACION
|j 38944 00002
|e 20050524
|
| 929 |
|
|
|d 0
|b María Blasco
|a DONACION
|j 38944 00003
|e 20050608
|
| 942 |
|
|
|c REV
|